A Retrospective Cohort Study of Treatment Outcomes of Adult Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma (ReCORD-FL)

被引：5
|
作者：
Salles, Gilles
Schuster, Stephen J.
Fischer, Luca
Kuruvilla, John
Patten, Piers E. M.
Tresckow, Bastianvon
Smith, Sonali M.
Jiminez Ubieto, Ana Isabel
Davis, Keith L.
Nagar, Saurabh P.
Zhang, Jie
Bollu, Vamsi
Jousseaume, Etienne
Ramos, Roberto
Wang, Yucai
Link, Brian K.
机构：
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-145870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1349
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Characteristics of spinal dissemination in adult low-grade glioma: a retrospective cohort study at a single institute
    Chen, Jianxin
    Shi, Qi
    Li, Shan
    Zhao, Yuze
    Huang, Hongyan
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (12) : 12643 - 12649
  • [42] Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL)
    Schuster, Stephen J.
    Dickinson, Michael
    Dreyling, Martin
    Martinez-Lopez, Joaquin
    Kolstad, Arne
    Butler, Jason
    Ghosh, Monalisa
    Popplewell, Leslie
    Chavez, Julio C.
    Bachy, Emmanuel
    Kato, Koji
    Harigae, Hideo
    Kersten, Marie Jose
    Andreadis, Charalambos
    Riedell, Peter
    Zia, Aiesha
    Morisse, Mony Chenda
    Fowler, Nathan Hale
    Thieblemont, Catherine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S403 - S404
  • [43] ETHNIC SENSITIVITY ASSESSMENT OF MOSUNETUZUMAB PHARMACOKIN ETICS (PK) IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (FL)
    Liao, M.
    Li, J.
    Wilkins, J.
    Wang, B.
    Vadhavkar, S.
    Peng, K.
    Zhang, Y.
    Li, D.
    Zhou, M.
    Li, C.
    Li, C.
    Turner, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S64 - S65
  • [44] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
    Ghione, Paola
    Palomba, Maria Lia
    Ghesquieres, Herve
    Bobillo, Sabela
    Patel, Anik R.
    Nahas, Myrna
    Kanters, Steve
    Deighton, Kevin
    Hatswell, Anthony
    Ma, Long
    Oldfield, Eve H. Limbrick-
    Snider, Julia Thornton
    Wade, Sally W.
    Riberio, Maria Teresa
    Radford, John
    Beygi, Sara
    Gribben, John
    HAEMATOLOGICA, 2023, 108 (03) : 822 - 832
  • [45] Retrospective Analysis of Treatment Outcomes for Patients with Follicular Lymphoma and Comorbidities
    Watanabe, Aya
    Imai, Yoichi
    Mitsuhashi, Kenjiro
    Shinohara, Akihito
    Tanaka, Norina
    Yoshinaga, Kentaro
    Shiseki, Masayuki
    Mori, Naoki
    Tanaka, Junji
    BLOOD, 2015, 126 (23)
  • [46] Phase II trial of Doxil® in patients with refractory/relapsed low-grade non-Hodgkin's lymphoma.
    Di Bella, NJ
    Khan, MM
    Dakhil, SR
    Logie, KW
    Marsland, TA
    Simon, SR
    Weinstein, RE
    BLOOD, 2000, 96 (11) : 236B - 236B
  • [47] Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study
    Tondini, C
    Balzarotti, M
    Rampinelli, I
    Valagussa, P
    Luoni, M
    De Paoli, A
    Santoro, A
    Bonadonna, G
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 231 - 233
  • [48] Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study
    Zhou, Juan
    Zheng, Hua
    Wu, San-Gang
    He, Zhen-Yu
    Li, Feng-Yan
    Su, Guo-Qiang
    Sun, Jia-Yuan
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 23 : 147 - 151
  • [49] TRANSCEND FL: phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
    Borchmann, Peter
    Morschhauser, Franck
    Dahiya, Saurabh
    Palomba, M. Lia
    Garcia-Sancho, Alejandro Martin
    Reguera Ortega, Juan Luis
    Kuruvilla, John
    Jaeger, Ulrich
    Cartron, Guillaume
    Izutsu, Koji
    Dreyling, Martin
    Kahl, Brad
    Ghesquieres, Herve
    Ardeshna, Kirit
    Goto, Hideki
    Barbui, Anna Maria
    Abramson, Jeremy S.
    Fleury, Isabelle
    Mielke, Stephan
    Farazi, Thalia
    Fasan, Omotayo
    Lymp, James
    Vedal, Min
    Nishii, Rina
    Avilion, Ariel
    Papuga, Jessica
    Nastoupil, Loretta J.
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 142 - 143
  • [50] Risk of secondary myeloid neoplasms following treatment in patients with grade I-II follicular lymphoma: a retrospective cohort study
    Wang, Yuebo
    Cai, Yanan
    DISCOVER ONCOLOGY, 2025, 16 (01)
12345